Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    50.0%

    Based on 1 completed trials

    Completion Rate
    50%(1/2)
    Active Trials
    0(0%)
    Results Posted
    200%(2 trials)
    Terminated
    1(25%)

    Phase Distribution

    Phase 3
    1
    25%
    Phase 1
    1
    25%
    Phase 2
    1
    25%

    Phase Distribution

    1

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution3 total trials
    Phase 1Safety & dosage
    1(33.3%)
    Phase 2Efficacy & side effects
    1(33.3%)
    Phase 3Large-scale testing
    1(33.3%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    50.0%

    1 of 2 finished

    Non-Completion Rate

    50.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(1)
    Terminated(1)
    Other(2)

    Detailed Status

    unknown2
    Completed1
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    50.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 11 (33.3%)
    Phase 21 (33.3%)
    Phase 31 (33.3%)

    Trials by Status

    completed125%
    unknown250%
    terminated125%

    Recent Activity

    0 active trials
    Showing 4 of 4
    unknownphase_1

    A Study to Assess PV-10 Chemoablation of Cancer of the Liver

    NCT00986661
    terminatedphase_3

    PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

    NCT02288897
    unknown

    Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

    NCT01260779
    completedphase_2

    Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

    NCT00521053

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT00986661Phase 1

    A Study to Assess PV-10 Chemoablation of Cancer of the Liver

    Unknown
    NCT02288897Phase 3

    PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

    Terminated
    NCT01260779

    Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

    Unknown
    NCT00521053Phase 2

    Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4